Brief: Alligator Bioscience Q4 Oper Loss Widens To SEK 52.6 Mln

Alligator Bioscience AB

10/02/2023 07:57

Feb 10 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * Q4 NET SALES SEK 20.1 MILLION VERSUS SEK 5.2 MILLION YEAR
AGO
    * Q4 OPERATING LOSS SEK 52.6 MILLION VERSUS LOSS SEK 36.9
MILLION
YEAR AGO
    * INTERIM RESULTS FROM MITAZALIMAB OPTIMIZE-1 PHASE 2 TRIAL
IN
PANCREATIC CANCER EXCEED 50% OBJECTIVE RESPONSE RATE

Source text for Eikon:  ID:nMFN9rccB8 
Further company coverage:  ATORX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))